Listen, you know, the Inflation Reduction act, on top of being the most significant investment in climate change in history, the provisions of that package that really took on prescription drugs and Big Pharma were so important. Next year Medicare will be able to negotiate with drug companies on 25 of the most commonly used drugs. Now, again, this only affects Medicare recipients. But like you said, with the $35 a month cap on insulin drugs, that again was only supposed to apply to Medicare. (10:35–10:46)
CLAIM
Asserts that Medicare will negotiate prices for 25 commonly used drugs starting next year.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
